Vericel Statistics
NASDAQ: VCELHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
57.52-0.74 (-1.27%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Vericel by the numbers
Vericel has a market capitalization of $2.94 billion based on 51.03M shares outstanding. Its trailing P/E ratio is 89.9, and its forward P/E is 61.1. The stock trades 28.7% above its 50-day average and 44.0% above its 200-day average.
Average daily trading volume is 664.34K shares, or about $38.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VCEL valuation vs. peer median
| Metric | VCEL | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.94B | $3.07B | -5% |
| Forward P/E | 61.1 | 14.1 | +334% |
| Avg. volume | 664.34K | 2.49M | -73% |
Peer median across 8 companies: DNLI, ADMA, IOVA, RLAY, TARS, BEAM, CRSP, BCRX.
Valuation
- Market cap
- $2.94B
- P/E (TTM)
- 89.88
- Forward P/E
- 61.06
- Price / sales (latest FY)
- 10.62
- EPS (TTM)
- $0.64
- Shares outstanding
- 51.03M
Price and trading
- Previous close
- 58.26
- Open
- 58.11
- Day range
- 57.33 – 59.49
- 52-week range
- 28.95 – 59.75
- 52-week change
- +45.33%
- Beta
- —
- Volume
- 582.32K
- Average volume
- 664.34K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 2.94B
- Pe
- 89.88
- Forward Pe
- 61.06
- Eps
- 0.64
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 59.75
- Week52 Low
- 28.95
- Avg Volume
- 664.34K
- Shares Outstanding
- 51.03M
- Ma50
- 44.69
- Ma200
- 39.94
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -3.73%
- Pct From52w Low
- 98.69%